Acta Med. 2013, 56: 57-66

https://doi.org/10.14712/18059694.2014.25

TLR2 AND TLR4 EXPRESSION ON BLOOD MONOCYTES AND GRANULOCYTES OF CARDIAC SURGICAL PATIENTS IS NOT AFFECTED BY THE USE OF CARDIOPULMONARY BYPASS

Jan Krejseka, Martina Koláčkováa, Jiří Manďákb, Pavel Kunešb, Zdeňka Holubcováb, Drahomíra Holmannováa, Mouhammed AbuAttieha, Ctirad Andrýsa

aCharles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, Czech Republic: Department of Clinical Immunology
bCharles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, Czech Republic: Department of Cardiac Surgery

References

1. Chew MS, Brandslund I, Brix-Christensen V, et al. Tissue injury and the inflammatory response to pediatric cardiac surgery with cardiopulmonary bypass. Anesthesiology 2001; 94: 745–753. <https://doi.org/10.1097/00000542-200105000-00010>
2. Chowdhury UK, Malik V, Yadav R, et al. Myocardial injury in coronary artery bypass grafting: On-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase MB, and myoglobin release. J Thorac Cardiovasc Surg 2008; 135: 1110–1119. <https://doi.org/10.1016/j.jtcvs.2007.12.029>
3. Wang Y, Abarbanell AM, Herrmann JL, et al. Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury. Shock 2010; 34: 548–557. <https://doi.org/10.1097/SHK.0b013e3181e686f5>
4. Svitek V, Lonsky V, Mandak J, et al. No clear clinical benefit of using miniinvasive extracorporeal circulation in coronary artery bypass grafting in low risk patients. Perfusion 2009; 24: 263–269. <https://doi.org/10.1177/0267659109359437>
5. Biancari F and Rimpiläinen R. Meta-analysis of randomised trials comparing the effectiveness of miniaturised versus conventional cardiopulmonary bypass in adult cardiac surgery. Heart 2009; 95: 964–969. <https://doi.org/10.1136/hrt.2008.158709>
6. Takagi H, Matsui M, Umemoto T. Off-pump coronary artery bypass may increase late mortality: a meta-analysis of randomized trials. Ann Thorac Surg 2010; 89: 1881–1888. <https://doi.org/10.1016/j.athoracsur.2010.03.010>
7. Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010; doi:10.1155/2010/672395. <https://doi.org/10.1155/2010/672395> <PubMed>
8. C. Erridge. The roles of Toll-like receptors in atherosclerosis. J Innate Immun 2009; 1: 340–349.
9. Hirsiger S, Simmen HP, Werner CM, et al. Danger signals activating the immune response after trauma. Mediators Inflamm 2012; doi:10.1155/2012/315941. <https://doi.org/10.1155/2012/315941> <PubMed>
10. Arslan F, Keogh B, McGuirk P, et al. TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm 2010; doi:10.1155/2010/704202. <https://doi.org/10.1155/2010/704202> <PubMed>
11. Krejsek J, Kunes P, Kolackova M, et al. Expression of Toll-like receptors 2 and 4 on innate immunity cells modulated by cardiac surgical operation. Scand J Clin Lab Invest 2008; 68: 749–758. <https://doi.org/10.1080/00365510802233434>
12. Kolackova M, Krejsek J, Svitek V, et al. The effect of conventional and mini-invasive cardiopulmonary bypass on neutrophil activation in patients undergoing coronary artery bypass grafting. Mediators Inflamm 2012; doi:10.1155/2012/152895. <https://doi.org/10.1155/2012/152895> <PubMed>
13. Jankovicova K, Kolackova M, Kunes P, et al. Interferon gamma receptor expression on granulocytes of cardiac surgical patients is modulated differently by the type of cardiopulmonary bypass. Perfusion 2012; 27: 49–55. <https://doi.org/10.1177/0267659111424635>
14. Russell SE, Walsh PT. Sterile inflammation – do innate lymphoid cell subsets play a role? Front Immunol 2012; 3: 1–6. <https://doi.org/10.3389/fimmu.2012.00246> <PubMed>
15. Dybdahl B, Wahba A, Lien E, et al. Inflammatory response after open heart surgery release of heat-shock protein 70 and signaling through Toll-like receptor-4. Circulation 2002; 105: 685–690. <https://doi.org/10.1161/hc0602.103617>
16. Franke A, Lante W, Fackeldey V, et al. Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know? Eur J Cardiothorac Surg 2005; 28: 569–575. <https://doi.org/10.1016/j.ejcts.2005.07.007>
17. Hadley JS, Wang JE, Michaels LC, et al. Alterations in inflammatory capacity and TLR expression on monocytes and neutrophils after cardiopulmonary bypass. Shock 27: 7466–7473.
18. Williams HJ, Fisher EA, Greaves DR. Macrophage differentiation and function in atherosclerosis: opportunities for therapeutic intervention. J Innate Immun 2012; doi:10.1159/2012/000336618. <https://doi.org/10.1159/2012/000336618>
19. Kunes P, Lonsky V, Mandak J, et al. The long pentraxin 3 in cardiac surgery: distinct responses in “on-pump” and “of pump” patients. Scand Cardiovasc J 2007; 41: 171–179. <https://doi.org/10.1080/14017430701324262>
20. Krejsek J, Mandak J, Kunes P, et al. Impact of methylprednisolone in priming solution of cardiopulmonary bypass on antiinflammatory CD163 receptor during cardiac surgery. Perfusion 2012; 27: 284–291. <https://doi.org/10.1177/0267659112439595>
21. Philippidis P, Athanasiou T, Nadra I, et al. Anti-inflammatory haemoglobin scavenging monocytes are induced following coronary artery bypass surgery. Eur J Cardiothorac Surg 2010; 37: 1360–1366. <https://doi.org/10.1016/j.ejcts.2009.12.043>
22. Versteeg D, Dol E, Hoefer IE, et al. Toll like receptor 2 and 4 response and expression on monocytes decrease rapidly in patients undergoing arterial surgery and are related to preoperative smoking. Shock 2009; 31: 21–27. <https://doi.org/10.1097/SHK.0b013e31817d43bf>
23. Hei Z, Chi X, Cheng N, et al. Upregulation of TLR2/4 expression in mononuclear cells in postoperative systemic inflammatory response syndrome after liver transplantation. Mediators Inflamm 2010; doi:10.1155/2010/519589. <https://doi.org/10.1155/2010/519589> <PubMed>
24. Liangos O, Domhan S, Schwager C, et al. Whole blood transcriptomics in cardiac surgery identifies a gene regulatory network connecting ischemia reperfusion with systemic inflammation. PLoS One 2010; 5: e13658. <https://doi.org/10.1371/journal.pone.0013658> <PubMed>
25. Kunes P, Holubcova Z, Kolackova M, et al. Pentraxin 3(PTX 3): An endogenous modulator of the inflammatory response. Mediators Inflamm 2012; doi:10.1155/2012/920517. <https://doi.org/10.1155/2012/920517> <PubMed>
26. Åkerfeldt T, Larsson A. Pentraxin 3 increase is much less pronounced than C-reactive protein increase after surgical procedures. Inflammation 2010; 34: 367–370. <https://doi.org/10.1007/s10753-010-9243-y>
27. Castellheim A, Hoel TN, Videm V, et al. Biomarker profile in off-pump and onpump coronary artery bypass grafting surgery in low-risk patients. Ann Thorac Surg 2008; 85: 1994–2002. <https://doi.org/10.1016/j.athoracsur.2008.03.012>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive